253
Participants
Start Date
May 13, 2023
Primary Completion Date
March 23, 2025
Study Completion Date
May 31, 2026
T2D care package
T2D care package including lifestyle counselling, firstline antidiabetic (metformin) and lipid-lowering (statin) treatment for uncomplicated T2D and treatment support and regular check-ups for complicated T2D at village-level. Guidance will be provided via the ComBaCaL app. In case of complicated disease referral to the closest health facility for further management.
Referral to the responsible health facility
CC-VHWs will refer participants to the responsible health facility for therapeutic management. The ComBaCaL app supports clinical decision making and documentation for screening, diagnosis and referral, but not prescription/provision and monitoring of antidiabetic or lipid-lowering medication for uncomplicated T2D patients or treatment support for complicated T2D patients.
University of Basel, Division of Clinical Epidemiology, Basel
SolidarMed Lesotho, Maseru
Swiss Agency for Development and Cooperation (SDC)
UNKNOWN
World Diabetes Foundation (WDF)
UNKNOWN
SolidarMed
OTHER
University Hospital, Basel, Switzerland
OTHER